Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com